Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Artia Global Partners LP
Form 13F · Q2 2026

Artia Global Partners LP

CIK 1937964申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$5.4亿
申报组合市值
48
持仓数量
12
Quarters on record
Top 50
持仓数量

Artia Global Partners LP——持仓

共 48 个持仓中的前 47 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1ABVX Abivax Sa516,447−14.0%$6882万12.7%
2INSM Insmed Inc589,052−6.3%$6280万11.6%
3TRVI Trevi Therapeutics Inc2.2M+9.8%$4123万7.6%
4BTSG Brightspring Health Svcs Inc517,315+861.6%$3608万6.7%
5RVMD Revolution Medicines Inc185,390+48.3%$3472万6.4%
6ARGX Argenx Se29,739+0.0%$2759万5.1%
7ALKS Alkermes Plc448,964—$2352万4.3%
8TVTX Travere Therapeutics Inc339,033+379.5%$1926万3.6%
9AZN Astrazeneca Plc98,376+3.1%$1865万3.4%
10NAMS Newamsterdam Pharma Company503,936+0.0%$1708万3.2%
11DNTH Dianthus Therapeutics Inc162,990+0.0%$1589万2.9%
12DGX Quest Diagnostics Inc65,122+59.5%$1380万2.5%
13IONS Ionis Pharmaceuticals Inc144,376+0.0%$1145万2.1%
14EYPT Eyepoint Inc767,098+0.0%$1097万2.0%
15ALMS Alumis Inc278,546−14.3%$784万1.4%
16VKTX Viking Therapeutics Inc180,731+0.0%$705万1.3%
17CELC Celcuity Inc59,316+280.8%$621万1.1%
18CYTK Cytokinetics Inc70,700+333.7%$602万1.1%
19MRK Merck & Co Inc46,700+0.0%$600万1.1%
20RAPP Rapport Therapeutics Inc138,508+0.0%$577万1.1%
21JNJ Johnson & Johnson22,600+0.0%$574万1.1%
22GH Guardant Health Inc38,100—$572万1.1%
23ABSI Absci Corporation464,444—$538万1.0%
24SRRK Scholar Rock Hldg Corp96,285+0.0%$530万1.0%
25SION Sionna Therapeutics Inc119,741+0.0%$527万1.0%
26ASND Ascendis Pharma A/S17,740—$473万0.9%
27ROIV Roivant Sciences Ltd129,800+0.0%$459万0.8%
28PALI Palisade Bio Inc2.0M+0.0%$416万0.8%
29EWTX Edgewise Therapeutics Inc98,800+50.8%$401万0.7%
30BIIB Biogen Inc18,437+0.0%$398万0.7%
31XENE Xenon Pharmaceuticals Inc65,000+0.0%$392万0.7%
32BLTE Belite Bio Inc24,989+0.0%$385万0.7%
33MLYS Mineralys Therapeutics Inc137,800+0.0%$372万0.7%
34PROK Prokidney Corp1.8M+0.0%$369万0.7%
35ELVN Enliven Therapeutics Inc72,100+245.0%$366万0.7%
36ORKA Oruka Therapeutics Inc33,400—$318万0.6%
37PTGX Protagonist Therapeutics Inc22,951+0.1%$281万0.5%
38UTHR United Therapeutics Corp Del5,000+0.0%$271万0.5%
39DRUG Bright Minds Biosciences Inc38,407+0.0%$270万0.5%
40KNSA Kiniksa Pharmaceuticals Intl29,200+0.0%$187万0.3%
41CMPX Compass Therapeutics Inc383,200—$84万0.2%
42PRAX Praxis Precision Medicines I2,500+0.0%$84万0.2%
43KOD Kodiak Sciences Inc17,019+0.0%$66万0.1%
44TENX Tenax Therapeutics Inc42,080+0.0%$61万0.1%
45NUVALENT INC Nuvalent Inc4,900+0.0%$61万0.1%
46PEPG Pepgen Inc205,324+0.0%$37万0.1%
47SYRE Spyre Therapeutics Inc4,000—$36万0.1%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。